Kobayashi Y, Nishiguchi Y, Kiguchi T, Ninomiya I, Watanabe F
Clinical Chemistry Laboratory, Kobe Women's College of Pharmacy, Japan.
J Steroid Biochem. 1987 Dec;28(6):759-67. doi: 10.1016/0022-4731(87)90409-2.
Comparative studies of 11 beta-, 18-, and 19-hydroxylation activities of 11-deoxycorticosterone (DOC) by bovine adrenal mitochondria revealed that an appreciable level of hydroxylation rate was observed in 19-hydroxylation (0.32 nmol/min/mg mitochondrial protein), as well as in 11 beta- and 18-hydroxylations (4.7 and 0.27 nmol/min/mg mitochondrial protein, respectively), at saturated substrate concentration in vitro. Also, the rates of the oxidation reactions of 19-hydroxy-11-deoxycorticosterone (19-OH-DOC) and 19-oxo-11-deoxycorticosterone (19-oxo-DOC) at the 19-position were about 5 times higher than the 19-hydroxylation rate of DOC. Although the affinities of 19-OH-DOC and 19-oxo-DOC for the enzyme(s) involved in the C-19 oxidation were about one-fifth those of DOC, these results strongly suggest the presence of the following pathway in bovine adrenal in vitro: DOC----19-OH-DOC----19-oxo-DOC----19-oic-DOC. This was further confirmed by a dynamic study of the formation and subsequent decay of the C-19 oxidized metabolites produced from DOC. At maximum concentrations of 19-OH-DOC and 19-oxo-DOC, the rates of production of, respectively, 19-oxo-DOC and 19-oic-DOC reached maximum. Furthermore, at the beginning of the incubation (1-4 min), an induction period in the formation of 19-oxo-DOC and 19-oic-DOC was observed and the formation of 19-oxo-DOC always preceded the appearance of 19-oic-DOC. These observations strongly support the existence of the pathway of the C-19 oxidation of DOC as mentioned above. It was also established that reduced pyridine nucleotide (NADPH) and molecular oxygen were required for these oxidation reactions. In addition, these three oxidation reactions were uniformly inhibited by the presence of carbon monoxide or metyrapone (0.01-1.0 microM), which is known to bind specifically with cytochrome P-450, while potassium cyanide (0.01-0.1 mM) did not affect them. These results suggest the possibility of the involvement of cytochrome P-450 in the C-19 oxidation reactions of DOC, 19-OH-DOC, and 19-oxo-DOC. We also showed that 19-oic-DOC is not further metabolized to other steroids such as 19-nor-11-deoxycorticosterone in bovine adrenal cortex.
对牛肾上腺线粒体中11 -脱氧皮质酮(DOC)的11β-、18 -和19 -羟化活性进行的比较研究表明,在体外底物浓度饱和时,19 -羟化反应(0.32 nmol/分钟/毫克线粒体蛋白)以及11β-和18 -羟化反应(分别为4.7和0.27 nmol/分钟/毫克线粒体蛋白)均观察到了可观的羟化速率。此外,19 -羟基-11 -脱氧皮质酮(19 - OH - DOC)和19 -氧代-11 -脱氧皮质酮(19 - oxo - DOC)在19位的氧化反应速率比DOC的19 -羟化速率高约5倍。尽管19 - OH - DOC和19 - oxo - DOC对参与C - 19氧化的酶的亲和力约为DOC的五分之一,但这些结果有力地表明在体外牛肾上腺中存在以下途径:DOC→19 - OH - DOC→19 - oxo - DOC→19 - oic - DOC。通过对由DOC产生的C - 19氧化代谢产物的形成及随后衰减的动态研究进一步证实了这一点。在19 - OH - DOC和19 - oxo - DOC的最大浓度时,19 - oxo - DOC和19 - oic - DOC的生成速率分别达到最大值。此外,在孵育开始时(1 - 4分钟),观察到19 - oxo - DOC和19 - oic - DOC形成有一个诱导期,且19 - oxo - DOC的形成总是先于19 - oic - DOC的出现。这些观察结果有力地支持了上述DOC的C - 19氧化途径的存在。还确定这些氧化反应需要还原型吡啶核苷酸(NADPH)和分子氧。此外,一氧化碳或美替拉酮(0.01 - 1.0 microM)的存在会均匀抑制这三种氧化反应,已知一氧化碳或美替拉酮会与细胞色素P - 450特异性结合,而氰化钾(0.01 - 0.1 mM)对它们没有影响。这些结果表明细胞色素P - 450可能参与了DOC、19 - OH - DOC和19 - oxo - DOC的C - 19氧化反应。我们还表明,在牛肾上腺皮质中19 - oic - DOC不会进一步代谢为其他类固醇,如19 -去甲-11 -脱氧皮质酮。